[cs]Stent[/cs] de [cs]strut[/cs] ultrafino liberador de everolimus en pacientes del mundo real: registro multic�ntrico �Everythin�
The use of the 50 µm UTS stent with a biodegradable everolimus-eluting polymer demonstrated a favorable safety profile and good clinical outcomes in unselected patients at 1 year of follow-up.
Authors
- Marcos García-Guimarães (ORCID: https://orcid.org/0000-0001-8509-6184)
- Eduard Bosch (ORCID: https://orcid.org/0000-0001-6615-9231)
- Kristian Rivera (ORCID: https://orcid.org/0000-0002-6598-3576)
- Diego Fernández-Rodríguez (ORCID: https://orcid.org/0000-0002-2793-3631)
- Daniel Valcárcel-Paz (ORCID: https://orcid.org/0000-0001-7503-3446)
- J. Casanova (ORCID: https://orcid.org/0000-0002-6894-2809)
- Gema Miñana-Escrivà
- Juan Francisco Muñoz-Camacho
- Agustín Fernández-Cisnal
Institutions
- Universitat Autònoma de Barcelona (ES)
- Hospital Universitari Arnau de Vilanova (ES)
- Hospital Clínico Universitario de Valencia (ES)
- University Hospital Mútua de Terrassa (ES)
- Hospital de Sabadell (ES)
- Mútua Terrassa (ES)
- Instituto de Investigación Biomédica de Lleida (ES)
- INCLIVA Health Research Institute (ES)
Publication Details
- Journal
- REC, Interventional cardiology
- Published
- 2024-10-23
- DOI
- https://doi.org/10.24875/recic.m24000484
- Primary Topic
- Central Venous Catheters and Hemodialysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00